Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.
暂无分享,去创建一个
Y. Rustum | H. Slocum | K. Toth | S. Cao | F. Durrani | Sreenivasulu Chintala | A. Bhattacharya | Shousong Cao | Arup Bhattacharya